Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

M. Brenner, Barry; E. Cooper, Mark; de Zeeuw, Dick; F. Keane, William; E. Mitch, William; Parving, Hans‐Henrik; Remuzzi, Giuseppe; Snapinn, Steven; Zhang, Zhonxin; Shahinfar, Shahnaz

doi:10.1056/nejmoa011161

Public

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Published in New England Journal of Medicine • Sep 20, 2001

Authors:

Barry M. Brenner

Mark E. Cooper

Dick de Zeeuw

Abstract

BACKGROUND: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the renin-angiotensin system slows the progression of renal disease in patients with type 1 diabetes, but similar data are not available for patients with type 2, the most common form of diabetes. We as...

Subject

Medicine

Losartan

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!